Drug developer C4X shares fly after signing £330m AstraZeneca licensing deal - City A.M.

Retrieved on: 2022-11-28 08:47:19

Tags for this article:

Click the tags to see associated articles and topics

Drug developer C4X shares fly after signing £330m AstraZeneca licensing deal - City A.M.. View article details on hiswai:

Excerpt

Drug developer C4X Discovery has signed an exclusive licensing agreement worth up to $402m (£334m) with pharma giant AstraZeneca to develop oral ...

Article found on: www.cityam.com